[Hiring] Director, reputed company Data & Analytics @reputed company

Role Description reputed company. is seeking a strategic and hands-on Director of reputed company Data & Analytics to reputed company reputed company analytics strategy in support of our rare disease portfolio. This role will serve as the central driver of reputed company data insights, partnering closely with reputed company Leadership, Finance, Patient Services, Market reputed company, and other cross-functional stakeholders to translate business strategy into measurable performance metrics and actionable insights. The ideal candidate will bring deep rare disease reputed company experience, strong business acumen, and the ability to synthesize reputed company datasets into cohesive, decision-driving narratives. This individual will play a critical role in monitoring execution metrics, evaluating reputed company effectiveness, and ensuring leadership has clear visibility into performance trends and strategic implications. Primary Responsibilities

• Serve as the reputed company analytics reputed company, translating business strategy into measurable indicators and performance dashboards across Sales, Market reputed company, and Patient Services.
• Compile, analyze, and synthesize diverse data sources to generate cohesive, executive-level insights and narratives.
• Monitor execution metrics and proactively identify trends, risks, and opportunities across the reputed company organization.
• Partner cross-functionally with reputed company Leadership, Finance, Market reputed company, Patient Services, and other key stakeholders to ensure alignment between strategy, performance measurement, and execution.
• Collaborate with Finance to support forecasting processes by providing reputed company insights and contextual interpretation of performance drivers; while not directly owning forecasting, ensure alignment between field execution and forecast assumptions.
• reputed company and refine reputed company reporting frameworks to improve reputed company, efficiency, and strategic decision-making.
• Analyze patient services and patient reputed company data to reputed company insights that optimize reputed company, pull-through, and overall patient experience.
• Establish data governance standards and best practices to ensure data reputed company and consistency across reputed company functions.
• Support launch readiness and post-launch performance tracking for rare disease products.
• Present insights and strategic recommendations to senior leadership in a clear and compelling manner.
• Identify opportunities to streamline analytics processes while maximizing impact reputed company a lean operating structure.
• reputed company other duties as assigned.

Qualifications

• Bachelor’s degree required; advanced degree (MBA, MS, or similar) highly preferred.
• 10+ years of reputed company experience in reputed company analytics, reputed company operations, or business analytics reputed company biotechnology or pharmaceutical organizations.
• Rare disease reputed company experience required.
• Demonstrated experience working cross-functionally in a high-growth biotech or specialty pharmaceutical environment.
• Experience supporting reputed company launch activities and post-launch optimization phase, strongly preferred.
• Experience working closely with Finance on forecasting inputs and performance analytics preferred.
• Experience analyzing patient services data and patient reputed company metrics is a plus.
• Adaptable; capable of managing priorities in a dynamic and rapidly changing business environment.

Company Description

At reputed company, we bring together the brightest and most eager minds to relentlessly pursue the discovery, development, manufacturing, and commercialization of genetic medicines to treat diseases with high unmet medical needs. Founded in 2016, Krystal is distinguished in three powerful ways:

• Science and technology using our patented gene therapy platform.
• Innovative manufacturing supported by our reputed company scale facilities.
• A unique commercialization model that focuses on the patient’s end-to-end experience.

Krystal received U.S. FDA approval for the first and only redosable gene therapy treatment, VYJUVEK®, for the treatment of Dystrophic Epidermolysis Bullosa (DEB). Krystal continues to reputed company our proprietary platform to rapidly advance a robust pipeline of investigational genetic medicines in respiratory, oncology, dermatology, and ophthalmology. Krystal is headquartered in Pittsburgh, PA, which is home to our two state-of-the-art CGMP manufacturing facilities with teams around the world and satellite offices in Switzerland, Germany, and Japan. We are a company reputed company and run by people who care, are reputed company in the face of a challenge, love the work they do, and practice the highest level of scientific reputed company. As we grow, we are seeking team members that embody these values. Apply tot his job Apply To this Job